JP2023071853A5 - - Google Patents

Download PDF

Info

Publication number
JP2023071853A5
JP2023071853A5 JP2023031534A JP2023031534A JP2023071853A5 JP 2023071853 A5 JP2023071853 A5 JP 2023071853A5 JP 2023031534 A JP2023031534 A JP 2023031534A JP 2023031534 A JP2023031534 A JP 2023031534A JP 2023071853 A5 JP2023071853 A5 JP 2023071853A5
Authority
JP
Japan
Prior art keywords
cells
seq
cell
nanoparticle
crispr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023031534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023071853A (ja
Filing date
Publication date
Priority claimed from PCT/US2017/066545 external-priority patent/WO2018112282A1/en
Application filed filed Critical
Publication of JP2023071853A publication Critical patent/JP2023071853A/ja
Publication of JP2023071853A5 publication Critical patent/JP2023071853A5/ja
Pending legal-status Critical Current

Links

JP2023031534A 2016-12-14 2023-03-02 核酸および/またはタンパク質ペイロード送達のための組成物および方法 Pending JP2023071853A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201662434344P 2016-12-14 2016-12-14
US62/434,344 2016-12-14
US201762443567P 2017-01-06 2017-01-06
US201762443522P 2017-01-06 2017-01-06
US62/443,522 2017-01-06
US62/443,567 2017-01-06
US201762517346P 2017-06-09 2017-06-09
US62/517,346 2017-06-09
PCT/US2017/066545 WO2018112282A1 (en) 2016-12-14 2017-12-14 Compositions and methods for nucleic acid and/or protein payload delivery
JP2019531758A JP2020502124A (ja) 2016-12-14 2017-12-14 核酸および/またはタンパク質ペイロード送達のための組成物および方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019531758A Division JP2020502124A (ja) 2016-12-14 2017-12-14 核酸および/またはタンパク質ペイロード送達のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2023071853A JP2023071853A (ja) 2023-05-23
JP2023071853A5 true JP2023071853A5 (cg-RX-API-DMAC7.html) 2023-10-05

Family

ID=62488586

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019531758A Pending JP2020502124A (ja) 2016-12-14 2017-12-14 核酸および/またはタンパク質ペイロード送達のための組成物および方法
JP2019531743A Active JP7317706B2 (ja) 2016-12-14 2017-12-14 核酸およびタンパク質ペイロード送達のための方法および組成物
JP2023031534A Pending JP2023071853A (ja) 2016-12-14 2023-03-02 核酸および/またはタンパク質ペイロード送達のための組成物および方法
JP2023117292A Pending JP2023134730A (ja) 2016-12-14 2023-07-19 核酸およびタンパク質ペイロード送達のための方法および組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019531758A Pending JP2020502124A (ja) 2016-12-14 2017-12-14 核酸および/またはタンパク質ペイロード送達のための組成物および方法
JP2019531743A Active JP7317706B2 (ja) 2016-12-14 2017-12-14 核酸およびタンパク質ペイロード送達のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023117292A Pending JP2023134730A (ja) 2016-12-14 2023-07-19 核酸およびタンパク質ペイロード送達のための方法および組成物

Country Status (10)

Country Link
US (5) US10975388B2 (cg-RX-API-DMAC7.html)
EP (2) EP3554555A4 (cg-RX-API-DMAC7.html)
JP (4) JP2020502124A (cg-RX-API-DMAC7.html)
KR (4) KR20240027888A (cg-RX-API-DMAC7.html)
CN (2) CN110582302A (cg-RX-API-DMAC7.html)
AU (2) AU2017378431A1 (cg-RX-API-DMAC7.html)
CA (2) CA3045131A1 (cg-RX-API-DMAC7.html)
IL (2) IL267034B2 (cg-RX-API-DMAC7.html)
RU (2) RU2019121801A (cg-RX-API-DMAC7.html)
WO (2) WO2018112278A1 (cg-RX-API-DMAC7.html)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210069016A1 (en) * 2008-11-13 2021-03-11 Gholam A. Peyman Neurodegenerative Disorder Treatment Method
CA3049980A1 (en) 2017-01-23 2018-07-26 Regeneron Pharmaceuticals, Inc. Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
CA3059348A1 (en) 2017-04-11 2018-10-18 Regeneron Pharmaceuticals, Inc. Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family
MY200418A (en) 2017-06-15 2023-12-25 Univ California Targeted non-viral dna insertions
KR102712142B1 (ko) 2017-07-31 2024-10-07 리제너론 파마슈티칼스 인코포레이티드 Cas-형질전환 마우스 배아 줄기 세포 및 마우스 및 이것의 용도
CN111182790A (zh) 2017-07-31 2020-05-19 瑞泽恩制药公司 Crispr报告体非人类动物及其用途
AU2018348195B2 (en) 2017-10-11 2025-05-15 Regeneron Pharmaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
SG11202003798TA (en) 2017-10-27 2020-05-28 Univ California Targeted replacement of endogenous t cell receptors
EP3592140A1 (en) 2018-03-19 2020-01-15 Regeneron Pharmaceuticals, Inc. Transcription modulation in animals using crispr/cas systems
MY207352A (en) 2018-03-21 2025-02-21 Regeneron Pharma 17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
US20200149070A1 (en) * 2018-04-24 2020-05-14 Ligandal, Inc. Methods and compositions for genome editing
WO2020051396A1 (en) * 2018-09-08 2020-03-12 Blueallele, Llc Methods and compositions for modifying the von willebrand factor gene
US12534728B2 (en) 2018-09-19 2026-01-27 Arrowhead Pharmaceuticals, Inc. RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of use
CN113423834A (zh) * 2018-11-08 2021-09-21 加总生物公司 微核小体核心蛋白及其在核酸递送中的用途
CN113195003B (zh) 2018-11-30 2024-12-31 国立大学法人京都大学 使用溶液的药物递送系统
CN119193710A (zh) * 2018-12-05 2024-12-27 弗莱德哈钦森癌症中心 遗传修饰细胞的减少和最少的操作制造
WO2020131862A1 (en) * 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
US11249941B2 (en) * 2018-12-21 2022-02-15 Palo Alto Research Center Incorporated Exabyte-scale data storage using sequence-controlled polymers
CN111363013B (zh) * 2018-12-25 2021-11-19 深圳先进技术研究院 多组分纳米颗粒簇的构建方法
CN109735540B (zh) * 2019-01-22 2022-05-31 南京鼓楼医院 SH2D1A基因、sgRNA及其应用
US20210379192A1 (en) * 2019-01-25 2021-12-09 Mantra Bio, Inc. Skeletal muscle targeting moieties and uses thereof
MA55082A (fr) 2019-03-01 2022-01-05 Flagship Pioneering Innovations Vi Llc Compositions, procédés, et kits pour l'administration de polyribonucléotides
KR102901623B1 (ko) 2019-03-01 2025-12-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 폴리리보뉴클레오티드 및 이의 미용적 용도
CA3138991A1 (en) * 2019-05-02 2020-11-05 Ligandal, Inc. Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
MX2022000045A (es) 2019-06-26 2022-04-20 Biorchestra Co Ltd Nanoparticulas micelares y sus usos.
JP7630904B2 (ja) * 2019-07-23 2025-02-18 株式会社東芝 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法
CN110628723B (zh) * 2019-09-05 2021-05-04 清华大学 基因修饰MSCs治疗2型糖尿病
US20210163935A1 (en) * 2019-09-05 2021-06-03 Trevor P. Castor Targeted Critical Fluid Nanoparticles Platform for Delivery of Nucleic Acids for Treatment of HIV-1 and Other Diseases
US12521451B2 (en) 2019-11-08 2026-01-13 Regeneron Pharmaceuticals, Inc. CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
CN112779317A (zh) * 2019-11-11 2021-05-11 香港中文大学深圳研究院 一种用于小分子核糖核酸检测的试剂及其应用
US20230248658A1 (en) * 2019-11-15 2023-08-10 The Regents Of The University Of California Supramolecular nanosubstrate-mediated delivery system enables crispr/cas9 knockin of hemoglobin beta gene-a potential therapeutic solution for hemoglobinopathies
US12663345B2 (en) 2020-01-13 2026-06-23 Illumina, Inc. Devices for generating monodisperse droplets from a bulk liquid
JP2023511279A (ja) 2020-01-13 2023-03-17 フルーエント バイオサイエンシーズ インコーポレイテッド 単一細胞シーケンシング
JP7562682B2 (ja) 2020-01-27 2024-10-07 マントラ バイオ,インコーポレイテッド キメラ小胞局在化部分を含む非天然発生の小胞、その産生方法、およびその使用
KR20220158723A (ko) * 2020-02-25 2022-12-01 리간달 인코포레이티드 생체모방 바이러스 펩티드의 확인 및 그의 용도
WO2021168575A1 (en) * 2020-02-27 2021-09-02 Quadrumix Biotechnology Inc. Polypeptides directed against viral infection and uses thereof
CA3175931A1 (en) 2020-03-16 2021-09-23 Fluent Biosciences Inc. Multi-omic analysis in monodisperse droplets
US12428685B2 (en) 2020-03-24 2025-09-30 Illumina, Inc. Viral detection using template emulsification
EP4136235A4 (en) * 2020-04-13 2024-10-16 Summation Bio, Inc. MINI-NUCLEOSOME CORE PROETIN AND THEIR USE IN NUCLEIC ACID DELIVERY
IL298363A (en) 2020-05-20 2023-01-01 Flagship Pioneering Innovations Vi Llc Immunogenic compositions and uses thereof
CA3189597A1 (en) 2020-07-15 2022-01-20 Fluent Biosciences Inc. Tiered ligation oligos
CN111968707B (zh) * 2020-08-07 2022-06-17 上海交通大学 基于能量的原子结构与电子密度图多目标优化拟合预测方法
CN111888333A (zh) * 2020-08-11 2020-11-06 深圳大学 一种转铁蛋白受体靶向的纳米胶束及其制备方法与应用
CN116685357A (zh) * 2020-08-21 2023-09-01 利甘达尔股份有限公司 纳米颗粒种子底物的组合物和方法
IL300947A (en) 2020-09-03 2023-04-01 Flagship Pioneering Innovations Vi Llc Immunogenic compositions and uses thereof
WO2022144811A1 (en) * 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
WO2022144812A1 (en) * 2020-12-30 2022-07-07 Biorchestra Co., Ltd. Micellar nanoparticles and uses thereof
CA3218849A1 (en) * 2021-05-14 2022-11-17 University Of Rochester Variants of sirt6 for use in preventing and/or treating age-related diseases
WO2022245868A1 (en) * 2021-05-18 2022-11-24 Fluent Biosciences Inc. Perturbed genomic expression in pretemplated instant partitions
WO2022251445A1 (en) 2021-05-28 2022-12-01 Fluent Biosciences Inc. Spatial transcriptomics in pips
US20230076395A1 (en) * 2021-08-17 2023-03-09 California Institute Of Technology Cell-to-cell delivery of rna circuits
KR102775653B1 (ko) * 2021-09-15 2025-03-05 한국기초과학지원연구원 아르기닌 리치 펩타이드를 포함하는 단백질 분해제 및 이를 이용한 단백질 이상질환의 예방 또는 치료용 약학적 조성물
MX2024003887A (es) 2021-10-14 2024-07-09 Arsenal Biosciences Inc Células inmunitarias que tienen arnch coespresados y sistemas de compuerta lógica.
EP4426475A4 (en) 2021-11-03 2025-12-24 Fluent Biosciences Inc DEVICES TO IMPROVE THE PREPARATION AND PROCESSING OF SAMPLES
AU2022408167A1 (en) 2021-12-08 2024-06-06 Regeneron Pharmaceuticals, Inc. Mutant myocilin disease model and uses thereof
CN115304756B (zh) * 2022-01-30 2023-05-09 上海科技大学 一种五元脂质纳米颗粒及其制备方法和应用
CN114480672B (zh) * 2022-02-22 2023-08-15 青岛农业大学 一种通过miR-145筛选高产肉率碱地黑牛的方法
CN114933658B (zh) * 2022-04-24 2023-07-11 深圳市鹏泰生物科技有限公司 一种短肽元件及其应用方法
CN115184480B (zh) * 2022-05-24 2024-07-09 南京中医药大学 一种用于鉴定华蟾素制剂或蟾皮的特征多肽及其含量测定方法与应用
CN115177734B (zh) * 2022-07-05 2025-03-14 中国人民解放军空军军医大学 一种靶向干预线粒体基因表达的工程化外泌体及其构建方法和应用
CN115350330B (zh) * 2022-09-01 2023-10-20 北京化工大学 一种负电性小分子调控的表面在蛋白差异性黏附上的应用
US12534721B2 (en) 2022-10-06 2026-01-27 Illumina, Inc. Quantitative detection and analysis of moleculesip
WO2024098238A1 (en) * 2022-11-08 2024-05-16 Pulsar Therapeutics Inc. Methods for treating hemoglobinopathies
WO2025049677A1 (en) * 2023-08-31 2025-03-06 Tufts Medical Center, Inc. Use of nanoparticles in therapeutic and imaging methods
AU2024367190A1 (en) * 2023-10-23 2026-04-23 The Board Of Regents Of The University Of Texas System Novel endoplasmic reticulum targeting signal peptides and uses thereof
CN117599200A (zh) * 2023-10-27 2024-02-27 华中科技大学 一种新型的双链rna递送载体及应用
CN122477215A (zh) * 2023-11-09 2026-07-28 得克萨斯州大学系统董事会 内源性突触靶向信号肽及其用途
WO2025207378A1 (en) * 2024-03-25 2025-10-02 Massachusetts Institute Of Technology Scalable and high throughput assembly of layer-by-layer nanoparticles
KR20250160320A (ko) * 2024-05-03 2025-11-12 한양대학교 산학협력단 엔도좀 탈출 효율이 향상된 항 인간 트랜스페린 수용체 항체, 및 이를 이용한 다중특이적 항체 및 약학 조성물
WO2026117631A2 (en) 2024-11-26 2026-06-04 City Therapeutics, Inc. Factor xi rnai agent compositions and methods of use thereof
WO2026152164A1 (en) 2025-01-13 2026-07-16 Sail Biomedicines, Inc. Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo

Family Cites Families (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US6379966B2 (en) 1999-02-26 2002-04-30 Mirus Corporation Intravascular delivery of non-viral nucleic acid
KR100535258B1 (ko) 1997-10-29 2005-12-09 도레이 카부시키가이샤 생분해성 및 발포성을 갖는 수지 조성물
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
BR0010705A (pt) 1999-04-30 2002-02-05 Amylin Pharmaceuticals Inc Exendinas modificadas e agonistas da exendina
US7098032B2 (en) 2001-01-02 2006-08-29 Mirus Bio Corporation Compositions and methods for drug delivery using pH sensitive molecules
AU2001257331A1 (en) 2000-04-28 2001-11-12 Sangamo Biosciences, Inc. Methods for designing exogenous regulatory molecules
US7355019B2 (en) 2000-06-06 2008-04-08 Sibtech, Inc. Cysteine-containing peptide tag for site-specific conjugation of proteins
US20030082561A1 (en) 2000-07-21 2003-05-01 Takashi Sera Zinc finger domain recognition code and uses thereof
US20030138453A1 (en) 2000-09-28 2003-07-24 O'hagan Derek Microparticles for delivery of heterologous nucleic acids
SI1724284T1 (sl) 2000-12-07 2009-12-31 Lilly Co Eli Glp-1 fuzijski proteini
US7273923B2 (en) 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US20040102606A1 (en) 2001-04-24 2004-05-27 Danuta Balicki Histone H2A -derived peptides useful in gene delivery
US6805904B2 (en) 2002-02-20 2004-10-19 International Business Machines Corporation Process of forming a multilayer nanoparticle-containing thin film self-assembly
EP1504092B2 (en) 2002-03-21 2014-06-25 Sangamo BioSciences, Inc. Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
EP1499895B1 (en) 2002-04-22 2008-05-07 University Of Florida Functionalized nanoparticles and methods of use
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
WO2004085998A2 (en) 2003-03-28 2004-10-07 The Children's Hospital Of Philadelphia Biomimetic hierarchies using functionalized nanoparticles as building blocks
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
EP2927318B1 (en) 2003-08-08 2020-05-20 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US20050053668A1 (en) 2003-08-21 2005-03-10 Southwest Research Institute Skeletally targeted nanoparticles
EP1748796A4 (en) 2004-03-05 2008-08-27 Univ Texas MULTILAYER NANOMEDICINE DELIVERY SYSTEM AND METHOD
DK1771206T3 (en) 2004-05-05 2018-05-22 Silence Therapeutics Gmbh LIPIDS, LIPID COMPLEXES AND USE THEREOF
WO2005123142A1 (en) 2004-06-10 2005-12-29 Abraxis Bioscience, Inc. A method using inorganic nanoparticles as non-viral vectors for gene therapy
US20060088599A1 (en) 2004-08-02 2006-04-27 Prasad Paras N Amino functionalized ORMOSIL nanoparticles as delivery vehicles
US20090220587A1 (en) * 2005-02-01 2009-09-03 United State Army Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
AU2007227202B2 (en) 2006-03-21 2013-08-22 Amylin Pharmaceuticals, Llc Peptide-peptidase inhibitor conjugates and methods of using same
SI2019683T2 (sl) 2006-04-25 2022-10-28 The Regents Of The University Of California Dajanje rastnih faktorjev za zdravljenje motenj CŽS
US7928186B2 (en) * 2006-08-02 2011-04-19 Phoenix Pharmaceuticals, Inc. Cell permeable bioactive peptide conjugates
JP2010500029A (ja) 2006-08-11 2010-01-07 ダウ アグロサイエンシィズ エルエルシー ジンクフィンガーヌクレアーゼ媒介相同組換え
WO2008103276A2 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
US20100196492A1 (en) 2007-03-08 2010-08-05 Green Jordan J Electrostatic coating of particles for drug delivery
TWI428135B (zh) 2007-03-26 2014-03-01 Hirofumi Takeuchi And a carrier composition for quick-acting nucleic acid delivery
AU2008305590A1 (en) 2007-09-27 2009-04-02 Sangamo Therapeutics, Inc. Genomic editing in zebrafish using zinc finger nucleases
EP2597155B1 (en) 2007-10-25 2016-11-23 Sangamo BioSciences, Inc. Methods and compositions for targeted integration
US8389485B2 (en) 2007-10-29 2013-03-05 University Of Massachusetts Encapsulated nanoparticles for nucleic acid delivery
WO2009059309A2 (en) 2007-11-01 2009-05-07 Panacea Pharmaceuticals, Inc. Furin-cleavable peptide linkers for drug-ligand conjugates
US8323618B2 (en) 2007-11-07 2012-12-04 University Of Houston System Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
CN101970687A (zh) 2007-11-09 2011-02-09 东北大学 用于体内基因输送的自组装胶束样纳米颗粒
GB0725321D0 (en) 2007-12-31 2008-02-06 Syntaxin Ltd Delivery vehicles
US7999025B2 (en) 2008-01-28 2011-08-16 University Of Utah Research Foundation Asymmetrically-functionalized nanoparticles organized on one-dimensional chains
US8344116B2 (en) * 2008-03-17 2013-01-01 Case Western Reserve University Polymers and complexes for delivery of nucleic acids to intracellular targets
US8324333B2 (en) 2008-06-05 2012-12-04 Wisconsin Alumni Research Foundation Anionic charge-dynamic polymers for release of cationic agents
US8404636B2 (en) * 2008-07-17 2013-03-26 George Mason Intellectual Properties, Inc. Targeted delivery of antimicrobial agents
CA2739608A1 (en) * 2008-10-07 2010-04-15 The Regents Of The University Of California Recombinant nell protein production
EP3699172A3 (en) 2008-11-10 2020-11-18 Arbutus Biopharma Corporation Novel lipids and compositions for the delivery of therapeutics
EP3156494B8 (en) 2008-12-04 2018-09-19 Sangamo Therapeutics, Inc. Genome editing in rats using zinc-finger nucleases
CA2757831C (en) 2009-04-07 2017-09-26 Dow Agrosciences Llc Nanoparticle mediated delivery of sequence specific nucleases
WO2011000095A1 (en) * 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
US20110077581A1 (en) * 2009-09-25 2011-03-31 Georgia Tech Research Corporation Targeted cellular delivery of nanoparticles
KR20120092611A (ko) 2009-09-30 2012-08-21 글락소 그룹 리미티드 연장된 반감기를 갖는 약물 융합체 및 컨쥬게이트
WO2011041897A1 (en) * 2009-10-06 2011-04-14 Angiochem Inc. Compositions and methods for the transport of therapeutic agents
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
WO2011096408A1 (ja) 2010-02-02 2011-08-11 国立大学法人 東京大学 複合体微粒子およびその製造方法、ならびに該複合体微粒子を用いた薬学組成物
KR101198715B1 (ko) 2010-05-14 2012-11-13 한국생명공학연구원 핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
WO2012012352A2 (en) * 2010-07-19 2012-01-26 Amidebio, Llc Modified peptides and proteins
WO2012092339A2 (en) * 2010-12-28 2012-07-05 The Children's Hospital Of Philadelphia The design of hydrolytically releasable prodrugs for sustained release nanoparticle formulations
US9074187B2 (en) 2011-03-21 2015-07-07 Board Of Trustees Of The University Of Arkansas Nanostructural materials that increase mineralization in bone cells and affect gene expression through miRNA regulation and applications of same
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US20140115726A1 (en) 2011-04-05 2014-04-24 Cellectis New tale-protein scaffolds and uses thereof
CA2834375C (en) 2011-04-27 2020-07-14 Amyris, Inc. Methods for genomic modification
US8916696B2 (en) 2011-06-12 2014-12-23 City Of Hope Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use
WO2013058812A1 (en) * 2011-10-19 2013-04-25 President And Fellows Of Harvard College Targeted delivery to pancreatic islet endothelial cells
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
CZ201220A3 (cs) 2012-01-13 2013-07-17 Ústav organické chemie a biochemie Akademie ved CR, v.v.i. Lipopolyaminy sperminového typu pro konstrukci liposomálních transfekcních systému
EP2841056A4 (en) 2012-04-23 2015-09-16 Massachusetts Inst Technology STABLE LAYER COATED PARTICLES
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
TR201816986T4 (tr) 2012-06-08 2019-01-21 Nitto Denko Corp Terapötik ajan iletim formülasyonlarına yönelik lipitler.
EP2863892B1 (en) 2012-06-20 2017-11-08 University Of Waterloo Mucoadhesive nanoparticle delivery system
EP2931899A1 (en) 2012-12-12 2015-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
SG10201707569YA (en) 2012-12-12 2017-10-30 Broad Inst Inc Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
MX380562B (es) 2012-12-12 2025-03-12 Broad Inst Inc Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias.
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
EP3064585B1 (en) 2012-12-12 2020-02-05 The Broad Institute, Inc. Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
CA2893579A1 (en) 2012-12-13 2014-06-19 Dow Agrosciences Llc Dna detection methods for site specific nuclease activity
IL308158A (en) 2012-12-17 2023-12-01 Harvard College Rna-guided human genome engineering
US10227610B2 (en) 2013-02-25 2019-03-12 Sangamo Therapeutics, Inc. Methods and compositions for enhancing nuclease-mediated gene disruption
US9504747B2 (en) 2013-03-08 2016-11-29 Novartis Ag Lipids and lipid compositions for the delivery of active agents
PL2970463T3 (pl) * 2013-03-13 2018-04-30 Biocrine Ab Sposoby leczenia i/lub ograniczania rozwoju cukrzycy
ES2749624T3 (es) 2013-03-14 2020-03-23 Caribou Biosciences Inc Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
CN105408483A (zh) 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
JP2016512048A (ja) 2013-03-15 2016-04-25 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ CRISPR/Casシステムを使用した植物ゲノム操作
US20140273230A1 (en) 2013-03-15 2014-09-18 Sigma-Aldrich Co., Llc Crispr-based genome modification and regulation
US20140349400A1 (en) 2013-03-15 2014-11-27 Massachusetts Institute Of Technology Programmable Modification of DNA
US11332719B2 (en) 2013-03-15 2022-05-17 The Broad Institute, Inc. Recombinant virus and preparations thereof
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US20140364333A1 (en) 2013-03-15 2014-12-11 President And Fellows Of Harvard College Methods for Live Imaging of Cells
CN105263312A (zh) 2013-04-05 2016-01-20 美国陶氏益农公司 用于在植物基因组内整合外源序列的方法和组合物
DK3456831T3 (da) 2013-04-16 2021-09-06 Regeneron Pharma Målrettet modifikation af rottegenom
US10604771B2 (en) 2013-05-10 2020-03-31 Sangamo Therapeutics, Inc. Delivery methods and compositions for nuclease-mediated genome engineering
US20140349405A1 (en) 2013-05-22 2014-11-27 Wisconsin Alumni Research Foundation Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
US9873907B2 (en) 2013-05-29 2018-01-23 Agilent Technologies, Inc. Method for fragmenting genomic DNA using CAS9
EP3603679B1 (en) 2013-06-04 2022-08-10 President and Fellows of Harvard College Rna-guided transcriptional regulation
PT3049116T (pt) * 2013-09-23 2019-04-03 Rensselaer Polytech Inst Distribuição genética mediada por nanopartículas, edição genómica e modificação direcionada a ligantes em várias populações celulares
WO2015048577A2 (en) 2013-09-27 2015-04-02 Editas Medicine, Inc. Crispr-related methods and compositions
PL3057604T3 (pl) 2013-10-14 2021-12-20 Nanosphere Health Sciences Inc. Kompozycje nanocząstek i sposoby jako nośniki czynników nutraceutycznych przez błony komórkowe i bariery biologiczne
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
WO2015089419A2 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
CN107073028A (zh) 2013-12-13 2017-08-18 南洋理工大学 多层纳米颗粒及其制作方法和使用方法
EP3148583B1 (en) * 2014-06-02 2020-04-29 Li-Cor, Inc. Phthalocyanine probes and uses thereof
DK3221293T3 (da) 2014-11-18 2023-04-03 Arcturus Therapeutics Inc Ioniserbar kationisk lipid til RNA-afgivelse
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems

Similar Documents

Publication Publication Date Title
US12286632B2 (en) Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
Kabouridis Biological applications of protein transduction technology
Wadia et al. Protein transduction technology
JP2023071853A (ja) 核酸および/またはタンパク質ペイロード送達のための組成物および方法
US9982267B2 (en) Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
EP2418281A2 (en) Methods and compositions for delivering polynucleotides
US11629170B2 (en) Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
JPH09135683A (ja) 生理活性タンパク質p160
Baek et al. Gene transfection for stem cell therapy
JP6861438B2 (ja) Ets転写因子を発現する改変内皮細胞
JP2005505233A (ja) モジュラートランスフェクション系
CN110478322A (zh) 一种核酸药物复合物及其制备方法和应用
US12419915B2 (en) Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
JP2019534890A (ja) 遺伝子編集ツールによって機能化されたナノ粒子および関連する方法
Papadopoulou et al. The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders
CN116003524B (zh) 一种靶向cGAS的短肽、融合多肽及应用
KR101064914B1 (ko) 자가면역질환, 알러지성 질환 및 염증성 질환 치료용 약제 조성물 및 이의 전달 방법
KR20150124910A (ko) 세포 이동 촉진용 조성물
Patsch et al. Conditional mutagenesis by cell-permeable proteins: potential, limitations and prospects
RU2637371C2 (ru) Гистоны и биодеградируемые липиды как средство для доставки нуклеиновых кислот в клетки эукариот
Sharma et al. Emerging applications of extracellular vesicles in regenerative medicine and tissue engineering
EP4031563A1 (en) Vasculogenic fibroblasts
CN105051061A (zh) 用于扩增干细胞的组合物和方法
EP4488373A1 (en) Scan-based fusion proteins for modulating gene expression and methods of use
HK40118619A (en) Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos to a target eukaryotic cell, uses, methods and kits thereof